Funding for this research was provided by:
Y-mAbs Therapeutics
Article History
Accepted: 19 October 2022
First Online: 25 November 2022
Change Date: 24 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40272-023-00557-y
Declarations
:
: Editorial and medical writing services and open access fee were funded by Y-mAbs Therapeutics.
: JC has received consultancy fees from Y-mAbs Therapeutics<b>.</b> RS has received speaker fees from Y-mAbs Therapeutics. EF and BT declare that they have no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors were involved in the development, review, and approval of the manuscript. Critical review and approval were provided by all authors at each stage during development.